Literature DB >> 28482753

Dynamic treatment regimes, past, present, and future: A conversation with experts.

Eric B Laber1, Marie Davidian1.   

Abstract

We asked three leading researchers in the area of dynamic treatment regimes to share their stories on how they became interested in this topic and their perspectives on the most important opportunities and challenges for the future.

Entities:  

Keywords:  Optimal dynamic treatment regime; clinical trials; mHealth; sequential multiple assignment randomized trial; treatment sequence

Mesh：

Year:  2017        PMID： 28482753      PMCID： PMC5519448          DOI： 10.1177/0962280217708661

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN： 0962-2802            Impact factor:   3.021


  6 in total

1.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

2.  Re: Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.

Authors:  Andrew J Armstrong; Elizabeth L Garrett-Mayer; Mario Eisenberger
Journal:  J Natl Cancer Inst       Date:  2008-04-29       Impact factor: 13.506

3.  Reinforcement learning design for cancer clinical trials.

Authors:  Yufan Zhao; Michael R Kosorok; Donglin Zeng
Journal:  Stat Med       Date:  2009-11-20       Impact factor: 2.373

4.  Reinforcement learning strategies for clinical trials in nonsmall cell lung cancer.

Authors:  Yufan Zhao; Donglin Zeng; Mark A Socinski; Michael R Kosorok
Journal:  Biometrics       Date:  2011-03-08       Impact factor: 2.571

5.  Bayesian Dose-Finding in Two Treatment Cycles Based on the Joint Utility of Efficacy and Toxicity.

Authors:  Juhee Lee; Peter F Thall; Yuan Ji; Peter Müller
Journal:  J Am Stat Assoc       Date:  2015-06-01       Impact factor: 5.033

6.  Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.

Authors:  Peter F Thall; Christopher Logothetis; Lance C Pagliaro; Sijin Wen; Melissa A Brown; Dallas Williams; Randall E Millikan
Journal:  J Natl Cancer Inst       Date:  2007-10-30       Impact factor: 13.506
  6 in total
  1 in total

1.  Personalized treatment selection using data from crossover designs with carry-over effects.

Authors:  Chathura Siriwardhana; K B Kulasekera; Somnath Datta
Journal:  Stat Med       Date:  2019-10-21       Impact factor: 2.373
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.